newsfilter
← Latest News
Business Wire·

Epizyme Announces Date of Second Quarter 2021 Financial Results

Epizyme, (NASDAQ:EPZM), a fully integrated, commercial-stage biopharmaceutical company developing and delivering novel epigenetic therapies, today announced that management will host a conference call to discuss its second quarter 2021 financial results